MarketsandMarkets

High Potent Medicines Conference

18th - 19th April 2024

Boston, USA

Looking and the current market scenario, many companies are outsourcing the manufacture of their highly potent compounds for various reasons, mainly marketing. The escalation in the High Potent drug market is subjected to a variety of aspects such as the diversification of pharmaceutical manufacturers towards precision medicines such as HPAPI, increasing demand for oncology drugs & antibody-drug conjugates, and advancements in HPAPI manufacturing technologies.

We are delighted to announce our MarketsandMarkets High Potent Medicines Conference, scheduled to be on 18th - 19th April 2024, in Boston, USA. This conference will evidence the presence of some great minds in the Medical and Pharmaceutical industry bringing you the solutions to the challenges faced in advanced High Potent Medicines. Grab the opportunity to interact with them, 10+ hours of dedicated networking for two days in a row and meet your potential targets to create target revenue.

WHAT TO EXPECT

  • Process Development and scale up of HPAPI’s
  • Strategies for effective outsourcing partnership
  • Containment and Handling Strategies
  • Validation of cleaning procedures to avoid cross contamination
  • Regulatory Landscape
  • Hazard Assessment Classifications

  • Utilizing the best practices to ensure safe and efficient production of high potent medicines
  • Training sessions on complex high potent compounds handling and containment issues
  • Understanding the updated regulatory guidelines in the HPAPI process
  • Implementing response plans to react to an unplanned event
  • Knowing the outsourcing strategies to effectively build a reliable supply chain

From pharmaceutical and Biopharmaceutical manufacturing:

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

  • Research & Development
  • Manufacturing/Operations/Production
  • Maintenance
  • Engineering
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer

CONFERENCE AGENDA

Registration

08:00 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening Remarks from the Chairperson

08:55 - 09:00

IMPLEMENTATION AND INTERPRETATION OF ADVANCED MANUFACTURING PRACTICES IN HPAPI

Keynote Presentation - Overcoming the Challenges Associated with Containment in HPAPI Manufacturing with Respirator Innovation

09:00 - 09:30

Challenges for Analysts Handling APIs in the Lab

09:30 - 10:00

Disinfection/Sterilization Process

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

TBA

11:15 - 11:45

Pharmaceuticals and the environment: Impact, Stewardship, and Sustainability

11:45 - 12:15

TBA

12:15 - 12:45

RISK ASSESSMENTS & DECISION MAKING IN HPAPI

HPAPI Handling from Lab Bench to Pilot Plant within Chemical Development

12:45 - 13:15

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Process Improvement Through Change Initiatives and Cleaning/Equipment Validation

14:15 - 14:45

Panel Discussion: Revealing the Key Concerns of Each Perspective in High Potent Manufacturing and How that Directs their Decision Making

14:45 - 15:15

Revealing Novel PAT Assays for Biologic Detection at the Single Particle Scale to Avoid Cross Contamination

15:15 - 15:25

Gauging the Risk in the Cross-Contamination and Reprocessing of Medical and Pharma Devices to Increase Safety & Cost Effectiveness

15:25 - 15:40

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:40 - 16:25

Essential Elements of HPAPI Projects with Respect to Patient Safety and Operator

16:25 - 16:55

Applying Our Outmost Understandings with HPAPI Controls to Improve Sustainability, Safety and Efficient Production

16:55 - 17:25

Closing Remarks from the Chairperson

17:25 - 17:30

Drinks Reception & Networking

17:30 - 17:30

End of Day 1

17:30 - 17:30

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening remarks from the Chairman

09:00 - 09:10

DESIGNING ENGINEERING CONTROLS FOR HIGH POTENCY CONTAINMENT

Keynote Presentation- Trends and Outlook on Containment

09:10 - 09:40

Reserved Slot for Platinum Sponsor

09:40 - 10:10

How Should Risk, Hazard, and Uncertainty be Treated with Respect to Containment Controls?

10:10 - 10:25

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:25 - 11:10

Reserved Slot for Gold Sponsor

11:10 - 11:40

Completing and Presenting a Convincing Quantitative Cost-Benefit Analysis and Discovering ALL the benefits of a containment investment in HPAPI

11:40 - 12:10

Reserved Slot for Silver Sponsor

12:10 - 12:40

A Hygienist’s Perspective in Broadening facilities to manage exposure/Common Pitfalls in Industrial Hygiene with Highly Potent APIs and the Means to Avoid them

12:40 - 13:10

Lunch and Poster Presentation | One-to-One Networking Meetings

13:10 - 14:10

EFFECTIVE PLANT DESIGN - A VITAL COMPONENT OF MANUFACTURING

Exploring Advanced Technology for Next Generation Isolation Design

14:10 - 14:40

Uncovering How to Front-Load Facility Design so it goes Hand-in-Hand with Process Development

14:40 - 14:55

Reducing the environmental impact with optimized ventilation design

14:55 - 15:25

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:25 - 16:05

Guidelines and Practices for the most cost-effective large-scale production of HPAPI products

16:05 - 16:35

Ventilation requirements for occupational hygiene exposure

16:35 - 17:05

Closing Remarks from the Chairman

17:05 - 17:05

End of Conference

17:05 - 17:05

SPEAKERS

Dean Calhoun

Dean Calhoun

President, CEO, Affygility Soultions, USA

Jayen Diyora

Jayen Diyora

Sr. Manager, Cleaning Validation, Bristol Myers Squibb

Senior Representative CTS Europe Ltd.

Senior Representative CTS Europe Ltd.

, CTS Europe Ltd.

Senior Representative FPS

Senior Representative FPS

, FPS

Senior Representative BSP Pharmaceuticals

Senior Representative BSP Pharmaceuticals

BSP Pharmaceuticals,

Robert Sussman

Robert Sussman

Managing Director, SafeBridge Consultants, Inc.

ENQUIRE NOW

SPONSORS

FPS
CTS Europe Ltd Design
BSP Pharmaceuticals

PARTNERS

LOCATION

Venue

Boston, USA

PAST EVENT GALLERY